Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Knapp

Showing results (51-60 of 90) with videos related to

Pageof 9
Sort By:
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|January 1, 1983
Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125S E Kabawat, R C Bast, A K Bhan, et al.
Obstetrics and Gynecology|July 11, 1992
Prospective evaluation of serum CA 125 levels for early detection of ovarian cancerN Einhorn, K Sjövall, R C Knapp, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1979
Immunotherapy of a murine ovarian carcinoma with Corynebacterium parvum and specific heteroantiserum. I. Activation of peritoneal cells to mediate antibody-dependent cytotoxicityR C Bast, R C Knapp, A K Mitchell, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|January 1, 1989
Ovarian clear cell carcinoma. A clinicopathologic analysis of 44 casesA G Montag, E L Jenison, C T Griffiths, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1988
Biodistribution, pharmacokinetics and imaging of 131I-labelled OC125 in ovarian cancerH J Haisma, K R Moseley, A I Battaile, et al.
International Journal of Cancer|January 15, 1987
Co-expression of human cancer-associated epitopes on mucin moleculesM S Lan, R C Bast, M I Colnaghi, et al.
Gynecologic Oncology|September 1, 1989
Intraperitoneal radiolabeled OC 125 in patients with advanced ovarian cancerN J Finkler, M G Muto, A I Kassis, et al.
Gynecologic Oncology|August 1, 1992
Preoperative serum CA-125 levels in borderline tumors of the ovaryL W Rice, J M Lage, R S Berkowitz, et al.
Journal of the National Cancer Institute|February 1, 1980
Specificity of heteroantisera developed against purified populations of intact murine ovarian carcinoma cellsR C Bast, R C Knapp, V C Donahue, et al.
Gynecologic Oncology|January 1, 1989
Clear cell adenocarcinoma of the ovary: a clinical analysis and comparison with serous carcinomaE L Jenison, A G Montag, C T Griffiths, et al.
Pageof 9

Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|January 1, 1983
Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125S E Kabawat, R C Bast, A K Bhan, et al.
Obstetrics and Gynecology|July 11, 1992
Prospective evaluation of serum CA 125 levels for early detection of ovarian cancerN Einhorn, K Sjövall, R C Knapp, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1979
Immunotherapy of a murine ovarian carcinoma with Corynebacterium parvum and specific heteroantiserum. I. Activation of peritoneal cells to mediate antibody-dependent cytotoxicityR C Bast, R C Knapp, A K Mitchell, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|January 1, 1989
Ovarian clear cell carcinoma. A clinicopathologic analysis of 44 casesA G Montag, E L Jenison, C T Griffiths, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1988
Biodistribution, pharmacokinetics and imaging of 131I-labelled OC125 in ovarian cancerH J Haisma, K R Moseley, A I Battaile, et al.
International Journal of Cancer|January 15, 1987
Co-expression of human cancer-associated epitopes on mucin moleculesM S Lan, R C Bast, M I Colnaghi, et al.
Gynecologic Oncology|September 1, 1989
Intraperitoneal radiolabeled OC 125 in patients with advanced ovarian cancerN J Finkler, M G Muto, A I Kassis, et al.
Gynecologic Oncology|August 1, 1992
Preoperative serum CA-125 levels in borderline tumors of the ovaryL W Rice, J M Lage, R S Berkowitz, et al.
Journal of the National Cancer Institute|February 1, 1980
Specificity of heteroantisera developed against purified populations of intact murine ovarian carcinoma cellsR C Bast, R C Knapp, V C Donahue, et al.
Gynecologic Oncology|January 1, 1989
Clear cell adenocarcinoma of the ovary: a clinical analysis and comparison with serous carcinomaE L Jenison, A G Montag, C T Griffiths, et al.
Pageof 9